277 related articles for article (PubMed ID: 28058041)
1. Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.
Kantae V; Krekels EHJ; Esdonk MJV; Lindenburg P; Harms AC; Knibbe CAJ; Van der Graaf PH; Hankemeier T
Metabolomics; 2017; 13(1):9. PubMed ID: 28058041
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication.
Jian J; He D; Gao S; Tao X; Dong X
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004434
[TBL] [Abstract][Full Text] [Related]
3. Multivariate pharmacokinetic/pharmacodynamic (PKPD) analysis with metabolomics shows multiple effects of remoxipride in rats.
van den Brink WJ; Elassaiss-Schaap J; Gonzalez-Amoros B; Harms AC; van der Graaf PH; Hankemeier T; de Lange ECM
Eur J Pharm Sci; 2017 Nov; 109():431-440. PubMed ID: 28882765
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
Mussap M; Loddo C; Fanni C; Fanos V
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
[No Abstract] [Full Text] [Related]
5. Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean.
Bafiti V; Katsila T
OMICS; 2022 Oct; 26(10):542-551. PubMed ID: 36149303
[TBL] [Abstract][Full Text] [Related]
6.
He C; Liu Y; Wang Y; Tang J; Tan Z; Li X; Chen Y; Huang Y; Chen X; Ouyang D; Zhou H; Peng J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():15-23. PubMed ID: 30041085
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.
Colburn WA; Lee JW
Clin Pharmacokinet; 2003; 42(12):997-1022. PubMed ID: 12959633
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
[TBL] [Abstract][Full Text] [Related]
9. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen.
Loisios-Konstantinidis I; Cristofoletti R; Jamei M; Turner D; Dressman J
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33147873
[TBL] [Abstract][Full Text] [Related]
10. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
[TBL] [Abstract][Full Text] [Related]
11. Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients.
Corona G; Di Gregorio E; Buonadonna A; Lombardi D; Scalone S; Steffan A; Miolo G
Front Pharmacol; 2023; 14():1212634. PubMed ID: 37637412
[No Abstract] [Full Text] [Related]
12. Prediction of Intravenous Busulfan Clearance by Endogenous Plasma Biomarkers Using Global Pharmacometabolomics.
Lin YS; Kerr SJ; Randolph T; Shireman LM; Senn T; McCune JS
Metabolomics; 2016 Oct; 12(10):. PubMed ID: 28827982
[TBL] [Abstract][Full Text] [Related]
13. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes.
Tee KB; Ibrahim L; Hashim NM; Saiman MZ; Zakaria ZH; Huri HZ
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745841
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variability.
Chen L; Chen CS; Sun Y; Henry NL; Stringer KA; Hertz DL
Cancer Chemother Pharmacol; 2021 Sep; 88(3):475-483. PubMed ID: 34089352
[TBL] [Abstract][Full Text] [Related]
16. Pharmacometabonomics and personalized medicine.
Everett JR; Loo RL; Pullen FS
Ann Clin Biochem; 2013 Nov; 50(Pt 6):523-45. PubMed ID: 23888060
[TBL] [Abstract][Full Text] [Related]
17. Bundling arrows: improving translational CNS drug development by integrated PK/PD-metabolomics.
van den Brink WJ; Hankemeier T; van der Graaf PH; de Lange ECM
Expert Opin Drug Discov; 2018 Jun; 13(6):539-550. PubMed ID: 29519169
[TBL] [Abstract][Full Text] [Related]
18. Species differences in pharmacokinetics and pharmacodynamics.
Toutain PL; Ferran A; Bousquet-Mélou A
Handb Exp Pharmacol; 2010; (199):19-48. PubMed ID: 20204582
[TBL] [Abstract][Full Text] [Related]
19. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
